Preview

Злокачественные опухоли

Расширенный поиск

ХИРУРГИЧЕСКОЕ ЛЕЧЕНИЕ РАКА ТЕЛА МАТКИ

https://doi.org/10.18027/2224-5057-2014-3-72-80

Полный текст:

Аннотация

Статья  посвящена  одному  из наиболее  дискуссионных вопросов  современной  онкогинекологии —   вмешательствам  на регионарных лимфатических узлах при раке тела матки. Рассмотрены  аргументы их сторонников и противников.

Об авторах

В. М. Нечушкина
Российский онкологический научный центр им. Н. Н. Блохина
Россия
Контактная информация: Нечушкина Валентина Михайловна – ФГБНУ «РОНЦ  им. Н.Н.Блохина», drnechushkina@mail.ru, тел.:  +7 (926) 537-32-00


К. Ю. Морхов
Российский онкологический научный центр им. Н. Н. Блохина
Россия

Морхов Константин Юрьевич



В. В. Кузнецов
Российский онкологический научный центр им. Н. Н. Блохина
Россия
КузнецовВикторВасильевич


Список литературы

1. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide / Ferlay J., Shin H. R., Bray F., Forman D., Mathers C., Parkin D. M. // IARC CancerBase. — N 10. — Lyon, France: International Agency for Research on Cancer, 2010. — URL: http://globocan.iarc.fr (дата обращения 15.05.2012).

2. 426 cases of stage I endometrial carcinoma: a clinicopathological analysis / Marziale P., Atlante G., Pozzi M., Diotallevi F., Iacovelli A. // Gynecol. Oncol. — 1989. — Vol. 32, N 3. — P. 278—281.

3. Carcinoma of the Corpus Uteri / Creasman W. T., Odicino F., Maisonneuve P., Quinn M. A., Beller U., Benedet J. L., Heintz A. P. M., Ngan H. Y. S., Pecorelli S. // Int. J. Gynaecol. Obstet. — 2006. — Vol. 95 (suppl. 1). — P. S105—S144.

4. Adenocarcinoma of the endometrium: its metastatic lymph node potential. A preliminary report / Creasman W. T., Boronow R. C., Morrow C. P., DiSaia P. J., Blessing J. // Gynecol. Oncol. — 1976. — Vol. 4, N 3. — P. 239—243.

5. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study / Boronow R. C., Morrow C. P., Creasman W. T., DiSaia P. J., Silverberg S. G., Miller A., Blessing J. A. // Obstet. Gynecol. — 1984. — Vol. 63, N 6. — P. 825—832.

6. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study / Creasman W. T., Morrow C. P., Bundy B. N., Homesley H. D., Graham J. E., Heller P. B. // Cancer. — 1987. — Vol. 60, N 8 (suppl.). — P. 2035—2041.

7. Aalders J. G., Thomas G. Endometrial cancer-revisiting the importance of pelvic and para-aortic lymph nodes // Gynecol. Oncol. — 2007. — Vol. 104. — P. 222—231.

8. Orr J. W., Holimon J., Orr P. Stage I corpus cancer: is teletherapy necessary // Am. J. Obstet. Gynecol. — 1997. — Vol. 176. — P. 777—789.

9. Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma / Homesley H. D., Kadar N., Barrett R. J., Lentz S.S. / Am. J. Obstet. Gynecol. — 1992. — Vol. 167. — P. 1225—1230.

10. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients / Mariani A., Dowdy S., Cliby W., Haddock M. G., Keeney G. L., Lesnick T. G., Podratz K. C. // Gynecol. Oncol. — 2006. — Vol. 101. — P. 200—208.

11. Surgery and postoperative radiotherapy versus surgery alone for patients with stage 1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. PostOperative Radiation Therapy in Endometrial Carcinoma / Creutzberg C. L., van Putten W. L., Koper P. C., Lybeert M. L., Jobsen J. J., Warlam-Rodenhuis C. C., De Winter K. A., Lutgens L. C., van den Bergh A. C., van de Steen-Banasik E., Beerman H.,van Lent M. // Lancet. — 2000. — Vol. 355. — P. 1404—1411.

12. Trimble E., Kosary C., Park R. Lymph node sampling and survival in endometrial cancer // Gynecol. Oncol. — 1998. — Vol. 71. — P. 340—343.

13. COSA-NZ-UK Endometrial Cancer Study Groups. Pelvic lymphadenectomy in high-risk endometrial cancer // Int. J. Gynecol. Cancer. — 1996. — Vol. 6. — P. 102—107.

14. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study / ASTEC study group, Kitchener H., Swart A. M., Qian Q., Amos C., Parmar M. K. // Lancet. — 2009.— Vol. 373, N 9658. — P. 125—136.

15. Creasman W. T. The current status of lymphadenectomy in the management of endometrial cancer // Womens Health (Lond. Engl). — 2011. — Vol. 7, N 1. — P. 33—35.

16. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis // Todo Y., Kato H., Kaneuchi M., Watari H., Takeda M., Sakuragi N. // Lancet. — 2010. — Vol. 375, N 9721. — P. 1165—1172.

17. Therapeutic impact of para-aortic lymphadenectomy in patients with high-risk, early stage and advanced stage endometrial carcinoma / Suzuki Y., Todo Y., Okamoto K., Minobe S., Kato H. // Proceedings of the 13th Biennial Meeting of International Gynecologic Cancer Society, Prague, 23—26 Oct 2010. — Abs. 1433.

18. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial / Benedetti Panici P., Basile S., Maneschi F., Alberto Lissoni A., Signorelli M., Scambia G., Angioli R., Tateo S., Mangili G., Katsaros D., Garozzo G., Campagnutta E., Donadello N., Greggi S., Melpignano M., Raspagliesi F., Ragni N., Cormio G., Grassi R., Franchi M., Giannarelli D., Fossati R., Torri V., Amoroso M., Croce C., Mangioni C. // J. Natl. Cancer Inst. — 2008. — Vol. 100, N 23. — P. 1707—1716.

19. Outcome of high-risk stage IC, grade 3 compared with stage I endometrial carcinoma patients: the postoperative radiation therapy in endometrial carcinoma trial / Creutzberg C., van Putten W., Warlam-Rodenhuis C. C., van den Bergh A. C., de Winter K. A., Koper P. C., Lybeert M. L., Slot A., Lutgens L. C., Stenfert Kroese M. C., Beerman H., van Lent M; Postoperative Radiation Therapy in Endometrial Carcinoma Trial // J. Clin. Oncol. — 2004. — Vol. 22. — P. 1234—1241.

20. Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy / Onda T., Yoshikawa H., Mizutani K., Mishima M., Yokota H., Nagano H., Ozaki Y., Murakami A., Ueda K., Taketani Y. // Br. J. Cancer. — 1997. — Vol. 75. — P. 1836—1841.

21. Analysis of FIGO stage IIIc endometrial cancer patients / McMeekin D. S., Lashbrook D., Gold M., Johnson G., Walker J. L., Mannel R. // Gynecol. Oncol. — 2001.— Vol. 81. — P. 273—278.

22. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy / Nelson G., Randall M., Sutton G., Moore D., Hurteau J., Look K. // Gynecol. Oncol. — 1999. — Vol. 75. — P. 211—214.

23. Relationship between surgical-pathological risk factors and outcome in clinical stages I and II carcinoma of the endometrium. A Gynecologic Oncology Group study / Morrow C. P., Bundy B. N., Kumar R. J., Creasman W. T., Heller P., Homesley H. D., Graham J. E. // Gynecol. Oncol. — 1991. — Vol. 40, N 1. — P. 55—65.

24. Kim Y., Niloff J. Endometrial carcinoma: analysis of recurrence in patients treated with a strategy minimizing lymph node sampling and radiation therapy // Obstet. Gynecol. — 1993. — Vol. 82. — P. 175—180.

25. Should selective paraaortic lymphadenectomy be part of surgical staging for endometrial cancer / Faught W., Krepart G., Loctocki R., Heywood M. // Gynecol Oncol. — 1994. — Vol. 55. — P. 51—55.

26. Uterine papillary serous carcinoma: patterns of metastatic spread / Goff B., Kato D., Schmidt R., Ek M., Ferry J. A., Muntz H. G., Cain J. M., Tamimi H. K., Figge D. C., Greer B. E. // Gynecol. Oncol. – 1994. – Vol. 54. – P. 264–268.

27. Podratz K. C., Mariani A., Webb M. Staging and therapeutic value of lymphadenenctomy in endometrial cancer // Gynecol. Oncol. — 1998. — Vol. 70. —P. 163—164.

28. Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma / Doering D. L., Barnhill D. R., Weiser E. B., Burke T. W., Woodward J. E., Park R. C. // Obstet. Gynecol. — 1989. — Vol. 74. — P. 930—933.

29. Clinical value of intraoperative gross examination in endometrial cancer / Franchi M., Ghezzi F., Melpigano M., Cherchi P. L., Scarabelli C., Apolloni C., Zanaboni F. // Gynecol. Oncol. — 2000. — Vol. 76. — P. 357—361.

30. Goff B. A., Riche L. W. Assessment of depth of myometrial invasion in endometrial adenocarcinoma // Gynecol. Oncol. — 1990. — Vol. 38. — P. 46—48.

31. A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer / Case A. S., Rocconi R. P., Straughn J. M., Jr., Conner M., Novak L., Wang W., Huh W. K. // Obstet. Gynecol. — 2006. — Vol. 108. — P. 1375—1379.

32. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer / Frumovitz M., Slomovitz B. M., Singh D. K., Broaddus R. R., Abrams J., Sun C. C., Bevers M., Bodurka D. C. // J. Am. Coll. Surg. — 2004. — Vol. 199, N 3. — P. 388—393.

33. Predictors of final histology in patients with endometrial cancer / Frumovitz M., Singh D. K., Meyer L., Smith D. H., Wertheim I., Resnik E., Bodurka D. C. // Gynecol. Oncol. — 2004. — Vol. 95, N 3. — P. 463—468.

34. Accuracy of lymph node palpation to determine need for lymphadenectomy in gynecologic malignancies / Arango H. A., Hoffman M. S., Roberts W. S., DeCesare S. L., Fiorica J. V., Drake J. // Obstet. Gynecol. — 2000. — Vol. 95, N 4. — P. 553—556.

35. Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group study / Singh M., Zaino R., Filiaci V., Leslie K. K. // Gynecol. Oncol. — 2007. — Vol. 106, N 2. — P. 325—333.

36. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients / Chan J. K., Cheung M. K., Huh W. K., Osann K., Husain A., Teng N. N., Kapp D. S. // Cancer. — 2006. — Vol. 107, N 8. — P. 1823—1830.

37. Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis: a Gynecologic Oncology Group study / Creasman W. T., Zaino R., Major F. L., DiSaia P. J., Hatch K. D., Homesley H. D. // Am. J. Obstet. Gynecol. – 1998. – Vol. 178, N 1. – P. 62–65.

38. Surgical staging of early invasive epithelial ovarian tumors / Leblanc E., Querleu D., Narducci F., Chauvet M. P., Chevalier A., Lesoin A., Vennin P., Taieb S. // Semin. Surg. Oncol. — 2000. — Vol. 19. — P. 36—41.

39. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center / Abu-Rustum N., Alektiar K., Iasonos A., Lev G., Sonoda Y., Aghajanian C., Chi D. S., Barakat R. R. // Gynecol. Oncol. — 2006. — Vol. 103, N 2. — P. 714—718.

40. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial cancer / Cohn D., Huh D., Fowler J., Straughn J. M., Jr. // Obstet. Gynecol. — 2007. — Vol. 109, N 6. — P. 1388—1395.

41. Comparison of treatment strategies for endometrial adenocarcinoma: analysis of financial impact / Barnes M. N., Roland P., Straughn M., Kilgore L. C., Alvarez R. D., Partridge E. E. // Gynecol. Oncol. — 1999. — Vol. 74, N 3. — P. 443—447.

42. Stage IVb endometrial carcinoma: the role of cytoreductive surgery and determinants of survival / Bristow R. E., Zerbe M. J., Rosenshein N. B., Grumbine F. C., Montz F. J. // Gynecol. Oncol. — 2000. — Vol. 78, N 2.— P. 85—91.

43. Surgical stage IV endometrial carcinoma: a study of 47 cases / Goff B. A, Goodman A., Muntz H. G., Fuller A. F., Jr, Nikrui N., Rice L. W. // Gynecol. Oncol. — 1994. — Vol. 52, N 2. — P. 237—240.

44. The role of surgical cytoreductive surgery in stage IV endometrial carcinoma / Chi D. S., Welshinger M., Venkatraman E. S., Barakat R. R. // Gynecol. Oncol. — 1997. — Vol. 67, N 1. — P. 56—60.

45. Nodal distribution and its significance in FIGO stage III endometrial cancer / McMeekin D. S., Lashbrook D., Gold M., Scribner D. R., Kamelle S., Tillmanns T. D., Mannel R. // Gynecol. Oncol. — 2001. — Vol. 82, N 2. — P. 375—379.

46. Incidence and location of para-aortic lymph node metastases in gynecologic malignancies / Flanagan C., Mannel R., Walker J., Johnson G. A. // J. Am. Coll. Surg. — 1995. — Vol. 181, N 1. — P. 72—74.

47. Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients / Chan J. K., Urban R., Cheung M. K., Shin J. Y., Husain A., Teng N. N., Berek J. S., Walker J. L., Kapp D. S., Osann K. // Cancer. — 2007. — Vol. 109, N 12. — P. 2454—2460.

48. Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer? / Hsieh C. H., Chang Chien C. C., Lin H., Huang E. Y., Huang C. C., Lan K. C., Chang S. Y. // Gynecol. Oncol. — 2002. — Vol. 86, N 1. — P. 28—33.

49. 70. A clinical and pathologicstudy on para-aortic lymph node metastasis in endometrial carcinoma / Hirahatake K., Hareyama H., Sakuragi N., Nishiya M., Makinoda S., Fujimoto S. // J. Surg. Oncol. — 1997. — Vol. 65, N 2. — P. 82—87.

50. Otsuka I., Kubota T., Aso T. Lymphadenectomy and adjuvant therapy in endometrial carcinoma: role of adjuvant chemotherapy // Br. J. Cancer. — 2002. — Vol. 87, N 4. —P. 377—380.

51. Resection of lymph node metastases influences survival in stage IIIC endometrial cancer / Havrilesky L. J., Cragun J., Calingaert B., Synan I., Secord A. A., Soper J. T., Clarke-Pearson D. L., Berchuck A. // Gynecol. Oncol. — 2005. — Vol. 99, N 3. — P. 689—695.

52. Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes / Chuang L., Burke T., Tornos C., Marino B. D., Mitchell M. F., Tortolero-Luna G., Levenback C., Morris M., Gershenson D. M. // Gynecol. Oncol. — 1995. — Vol. 58, N 2. — P. 189—193.

53. Potential therapeutic role of para-aortic lymphadenectomy in node positive endometrial cancer / Mariani A., Webb M., Galli L., Podratz K. C. // Gynecol. Oncol. — 2000. — Vol. 76, N 3. — P. 348—356.

54. Detailed analysis of endometrial cancer patients who underwent resection of upper and lower para-aortic nodes during a lymphadenectomy / Koc S., Ozer S., Turan T., Keskin H. L., Ozfuttu A., Boran N., Tulunay G., Kose M. F. // Proceedings of the 13th Biennial Meeting of International Gynecologic Cancer Society, Prague, 23—26 Oct 2010. — Abs. 1486.

55. Systematic pelvic and paraaortic lymphadenectomy in endometrial cancer: lymph node metastasis pattern and identification of predictive factors for lymph-node status / El-Balat A., Fotopoulou C., Sehouli J., Heitz F., Muallem M. Z., Harter P., Kratschell R., du Bois A. // Proceedings of the 13th Biennial Meeting of International Gynecologic Cancer Society, Prague, 23—26 Oct 2010. — Abs. 160.

56. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling / Kilgore L. C., Partridge E. E., Alvarez R. D., Austin J. M., Shingleton H. M., Noojin F., 3rd, Conner W. // Gynecol. Oncol. — 1995. — Vol. 56, N 1. — P. 29—33.

57. Pelvic lymphadenectomy in the surgical treatment of endometrial cancer / Girardi F., Petru E., Heydarfadai M., Haas J., Winter R. // Gynecol. Oncol. — 1993. — Vol. 49, N 2. — P. 177—180.

58. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer / Cragun J. M., Havrilesky L. J., Calingaert B., Synan I., Secord A. A., Soper J. T., Clarke-Pearson D. L., Berchuck A. // J. Clin. Oncol. — 2005. — Vol. 23, N 16. — P. 3668—3675.

59. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study / Keys H. M., Roberts J. A., Brunetto V. L., Zaino R. J., Spirtos N. M., Bloss J. D., Pearlman A., Maiman M. A., Bell J. G.; Gynecologic Oncology Group // Gynecol. Oncol. — 2004. — Vol. 92, N 3. — P. 744—751.

60. Orton J., Blake P. Adjuvant external beam radiotherapy (EBRT) in the treatment of endometrial cancer: results of the randomized MRC ASTEC and NCIC CTG EN.5 trial // J. Clin. Oncol. — 2007. — Vol. 25, N 182. — Abs. 5504.

61. Long-term outcomes after pelvic radiation for early-stage endometrial cancer / Onsrud M., Cvancarova M., Hellebust T. P., Trope C. G., Kristensen G. B., Lindemann K. // J. Clin. Oncol. — 2013. — Vol. 31, N 31. — P. 3951—3956.

62. Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches / Barakat R. R., Lev G., Hummer A., Sonoda Y., Chi D. S., Alektiar K. M., Abu-Rustum N. R. // Gynecol. Oncol. — 2007. — Vol. 105, N 1. — P. 150—156.

63. The impact of complete surgical staging on adjuvant treatment decisions in endometrial cancer / Goudge C., Bernhard S., Cloven N., Morris P. // Gynecol. Oncol. — 2004. — Vol. 93, N 2. — P. 536—539.

64. Fanning J., Nanavati P., Hilgers R. Surgical staging and high dose rate brachytherapy for endometrial cancer: limiting external radiotherapy to node positive tumors // Obstet. Gynecol. — 1996. — Vol. 87. — P. 1041—1044.

65. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma / Mohan D., Samuels M., Selim M., Shalodi A. D., Ellis R. J., Samuels J. R., Yun H. J. // Gynecol. Oncol. — 1998. — Vol. 70, N 2. — P. 165—171.


Для цитирования:


Нечушкина В.М., Морхов К.Ю., Кузнецов В.В. ХИРУРГИЧЕСКОЕ ЛЕЧЕНИЕ РАКА ТЕЛА МАТКИ. Злокачественные опухоли. 2014;(3):72-80. https://doi.org/10.18027/2224-5057-2014-3-72-80

For citation:


Nechushkina V.M., Morkhov K.Y., Kuznetsov V.V. SURGICAL TREATMENT OF ENDOMETRIAL CANCER. Malignant tumours. 2014;(3):72-80. (In Russ.) https://doi.org/10.18027/2224-5057-2014-3-72-80

Просмотров: 663


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2224-5057 (Print)
ISSN 2587-6813 (Online)